{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:45:21Z","timestamp":1790891121824,"version":"4.1.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is a complex disorder in which metabolic abnormalities are associated with reproductive dysfunction. Women with PCOS have increased ceramide concentrations. Previous studies demonstrated that treating metabolic abnormalities of PCOS with metformin improved glucose effectiveness after 12 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We evaluated whether, in women with PCOS, lower baseline ceramide, diacylglycerol (DAG), and triacylglycerol (TAG) concentrations were associated with improved metabolic response to metformin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Women (n\u2009=\u200929), aged 29\u2009\u00b1\u20095 years and diagnosed with PCOS by the NIH criteria underwent an intravenous glucose tolerance test (IVGTT) before and after 12-week treatment with metformin (1500\u2005mg per day). Metabolic responders were defined by improved glucose effectiveness, specifically, the ability of glucose to stimulate uptake and suppress production, after metformin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve weeks of metformin resulted in weight loss (\u22121.7\u2009\u00b1\u20092.6\u2005kg, P\u2009&amp;lt;\u20090.01) and a reduction in BMI (\u22120.6\u2009\u00b1\u20090.9\u2005kg\/m2, P\u2009&amp;lt;\u20090.01) with no change in HbA1c. The concentrations of Cer(d18:1\/22:0), Cer(d18:1\/24:0), total ceramides, total Cer(d16:0), total Cer(d18:2), DAG, dihydrosphingomyelin (DHSM), and TAG decreased after metformin treatment (P\u2009&amp;lt;\u20090.05). Baseline total Cer(d16:0) concentration &amp;lt;204.1\u2005pmol\/mL was 82% sensitive (AUC 0.72, P\u2009=\u20090.03) and total DHSM concentration &amp;lt;32237\u2005pmol\/mL was 100% specific (AUC 0.73, P\u2009=\u20090.03) in predicting improved metabolic response to metformin, as measured by IVGTT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lower total Cer(16:0) and DHSM concentrations are associated with a beneficial metabolic response to metformin in women with PCOS. Based on the known association between higher ceramide levels and type 2 diabetes, the data suggest that metformin improves metabolic parameters in women with mild metabolic derangements.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvac131","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T14:38:03Z","timestamp":1662129483000},"source":"Crossref","is-referenced-by-count":10,"title":["The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS"],"prefix":"10.1210","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-2201","authenticated-orcid":false,"given":"Anu","family":"Sharma","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Krick","sequence":"additional","affiliation":[{"name":"Cancer Control and Population Sciences, Huntsman Cancer Institute , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nutrition & Integrative Physiology, University of Utah , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Summers","sequence":"additional","affiliation":[{"name":"Department of Nutrition & Integrative Physiology, University of Utah , Salt Lake City, UT , USA"},{"name":"Diabetes and Metabolism Research Center, University of Utah School of Medicine , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C","family":"Playdon","sequence":"additional","affiliation":[{"name":"Cancer Control and Population Sciences, Huntsman Cancer Institute , Salt Lake City, UT , USA"},{"name":"Department of Nutrition & Integrative Physiology, University of Utah , Salt Lake City, UT , USA"},{"name":"Diabetes and Metabolism Research Center, University of Utah School of Medicine , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Welt","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"12","key":"2022101309263136700_bvac131-B1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"1","key":"2022101309263136700_bvac131-B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"9","key":"2022101309263136700_bvac131-B3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"2","key":"2022101309263136700_bvac131-B4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2022101309263136700_bvac131-B5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2022101309263136700_bvac131-B6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ecl.2020.10.006","article-title":"Genetics of polycystic ovary syndrome: what is new?","volume":"50","author":"Welt","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2022101309263136700_bvac131-B7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"5","key":"2022101309263136700_bvac131-B8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/jc.2013-4021","article-title":"Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study","volume":"99","author":"Pau","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2022101309263136700_bvac131-B9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"issue":"3","key":"2022101309263136700_bvac131-B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"issue":"4","key":"2022101309263136700_bvac131-B11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"issue":"3","key":"2022101309263136700_bvac131-B12","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1152\/ajpendo.2000.279.3.E554","article-title":"Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle","volume":"279","author":"Ellis","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2022101309263136700_bvac131-B13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.2002.tb04272.x","article-title":"Protein kinase C and lipid-induced insulin resistance in skeletal muscle","volume":"967","author":"Schmitz-Peiffer","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2022101309263136700_bvac131-B14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic messengers: ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat Metab"},{"issue":"3","key":"2022101309263136700_bvac131-B15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"2022101309263136700_bvac131-B16","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"2022101309263136700_bvac131-B17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmet.2020.10.001","article-title":"Central ceramide signaling mediates obesity-induced precocious puberty","volume":"32","author":"Heras","year":"2020","journal-title":"Cell Metab"},{"issue":"5-6","key":"2022101309263136700_bvac131-B18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ando.2019.06.003","article-title":"Sphingosine-1-phosphate (S1P) in ovarian physiology and disease","volume":"80","author":"Hern\u00e1ndez-Coronado","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2022101309263136700_bvac131-B19","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/s41598-019-52263-w","article-title":"Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women","volume":"9","author":"Pradas","year":"2019","journal-title":"Sci Rep"},{"key":"2022101309263136700_bvac131-B20","volume-title":"Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"},{"issue":"2","key":"2022101309263136700_bvac131-B21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-2607(86)90106-9","article-title":"MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test","volume":"23","author":"Pacini","year":"1986","journal-title":"Comput Methods Programs Biomed"},{"issue":"5","key":"2022101309263136700_bvac131-B22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/metabo9050099","article-title":"Effects of long-term storage at -80 \u00b0C on the human plasma metabolome","volume":"9","author":"Wagner-Golbs","year":"2019","journal-title":"Metabolites"},{"issue":"5","key":"2022101309263136700_bvac131-B23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/ijms19051390","article-title":"Preanalytical biases in the measurement of human blood sphingolipids","volume":"19","author":"Brunkhorst","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2022101309263136700_bvac131-B24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1194\/jlr.P081281","article-title":"Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients","volume":"59","author":"Anroedh","year":"2018","journal-title":"J Lipid Res"},{"issue":"9","key":"2022101309263136700_bvac131-B25","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"2022101309263136700_bvac131-B26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"issue":"6","key":"2022101309263136700_bvac131-B27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/09513590.2019.1698026","article-title":"Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics","volume":"36","author":"Jiang","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2022101309263136700_bvac131-B28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JME-17-0023","article-title":"The association of the lipidomic profile with features of polycystic ovary syndrome","volume":"59","author":"Moran","year":"2017","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"2022101309263136700_bvac131-B29","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"2022101309263136700_bvac131-B30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2022101309263136700_bvac131-B31","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1210\/jc.2018-01771","article-title":"Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome","volume":"104","author":"Hansen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"2022101309263136700_bvac131-B32","doi-asserted-by":"crossref","first-page":"20088","DOI":"10.1074\/jbc.M111.330746","article-title":"Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells","volume":"287","author":"Turban","year":"2012","journal-title":"J Biol Chem"},{"issue":"35","key":"2022101309263136700_bvac131-B33","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"2022101309263136700_bvac131-B34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"2022101309263136700_bvac131-B35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2022101309263136700_bvac131-B36","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1038\/s41598-018-25397-6","article-title":"The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action","volume":"8","author":"Zabielski","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"2022101309263136700_bvac131-B37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"issue":"6451","key":"2022101309263136700_bvac131-B38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"issue":"25","key":"2022101309263136700_bvac131-B39","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"2022101309263136700_bvac131-B40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2019","journal-title":"Eur Heart J"},{"key":"2022101309263136700_bvac131-B41","author":"Mayo Clinic Laboratories"},{"issue":"1","key":"2022101309263136700_bvac131-B42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2018.10.009","article-title":"Ceramides as novel disease biomarkers","volume":"25","author":"Kurz","year":"2019","journal-title":"Trends Mol Med"},{"key":"2022101309263136700_bvac131-B43","doi-asserted-by":"crossref","first-page":"570628","DOI":"10.3389\/fendo.2020.570628","article-title":"Ceramides and ceramide scores: clinical applications for cardiometabolic risk stratification","volume":"11","author":"Hilvo","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022101309263136700_bvac131-B44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.acr.2018.04.016","article-title":"Novel sphingolipid-based cancer therapeutics in the personalized medicine era","volume":"140","author":"Shaw","year":"2018","journal-title":"Adv Cancer Res"},{"issue":"7","key":"2022101309263136700_bvac131-B45","first-page":"452","article-title":"Following Roux-en-Y gastric bypass surgery, serum ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission","volume":"3","author":"Poss","year":"2022","journal-title":"Med (N Y)"},{"issue":"6","key":"2022101309263136700_bvac131-B46","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1210\/clinem\/dgz326","article-title":"A polygenic and phenotypic risk prediction for polycystic ovary syndrome evaluated by phenome-wide association studies","volume":"105","author":"Joo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2022101309263136700_bvac131-B47","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"issue":"5","key":"2022101309263136700_bvac131-B48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1590\/S1807-59322009000500008","article-title":"Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen","volume":"64","author":"Lima","year":"2009","journal-title":"Clinics (Sao Paulo)"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac131\/45669832\/bvac131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/11\/bvac131\/46485241\/bvac131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/11\/bvac131\/46485241\/bvac131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T18:54:47Z","timestamp":1676660087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac131\/6687738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,10,11]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac131","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,9,2]]},"article-number":"bvac131"}}